{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T18:43:56Z","timestamp":1775933036913,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    is an important global pathogen for which new drugs are urgently required. The ability of the organism to survive and multiply within macrophages may contribute to the lengthy treatment regimen with multiple drugs that are required to cure the infection. We screened the MyriaScreen II diversity library of 10,000 compounds to identify novel inhibitors of\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    growth within macrophage-like cells using high content analysis. Hits were selected which inhibited the intramacrophage growth of\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    without significant cytotoxicity to infected macrophages. We selected and prioritized compound series based on their biological and physicochemical properties and the novelty of the chemotypes. We identified five chemical classes of interest and conducted limited catalog structure-activity relationship studies to determine their tractability. We tested activity against intracellular and extracellular\n                    <jats:italic>M<\/jats:italic>\n                    .\n                    <jats:italic>tuberculosis,<\/jats:italic>\n                    as well as cytoxicity against murine RAW264.7 and human HepG2 cells. Benzene amide ethers, thiophene carboxamides and thienopyridines were only active against intracellular bacteria, whereas the phenylthiourea series was also active against extracellular bacteria. One member of a phenyl pyrazole series was moderately active against extracellular bacteria. We identified the benzene amide ethers as an interesting series for further work. These new compound classes serve as starting points for the development of novel drugs to target intracellular\n                    <jats:italic>M<\/jats:italic>\n                    .\n                    <jats:italic>tuberculosis<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.3389\/fphar.2021.790583","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T03:23:58Z","timestamp":1641180238000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification of Novel Chemical Scaffolds that Inhibit the Growth of Mycobacterium tuberculosis in Macrophages"],"prefix":"10.3389","volume":"12","author":[{"given":"Sara","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Manning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Flint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia","family":"Ovechkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Parish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/infdis\/jiy710","article-title":"Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance","volume":"219","author":"Adams","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s13104-018-3798-3","article-title":"Codon-optimized DsRed Fluorescent Protein for Use in Mycobacterium tuberculosis","volume":"11","author":"Carroll","year":"2018","journal-title":"BMC Res. Notes"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1000645","DOI":"10.1371\/journal.ppat.1000645","article-title":"High Content Screening Identifies Decaprenyl-Phosphoribose 2' Epimerase as a Target for Intracellular Antimycobacterial Inhibitors","volume":"5","author":"Christophe","year":"2009","journal-title":"Plos Pathog."},{"key":"B4","doi-asserted-by":"publisher","first-page":"a018481","DOI":"10.1101\/cshperspect.a018481","article-title":"Autophagy in Tuberculosis","volume":"4","author":"Deretic","year":"2014","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"112402","DOI":"10.1016\/j.ejmech.2020.112402","article-title":"Design and Synthesis of Thiourea-Based Derivatives as Mycobacterium tuberculosis Growth and Enoyl Acyl Carrier Protein Reductase (InhA) Inhibitors","volume":"199","author":"Do\u011fan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13065-017-0271-7","article-title":"Synthesis, Docking Study and Biological Evaluation of Some New Thiourea Derivatives Bearing Benzenesulfonamide Moiety","volume":"11","author":"Ghorab","year":"2017","journal-title":"Chem. Cent. J."},{"key":"B7","unstructured":"Global Tuberculosis Report 2020 [Internet]2020"},{"key":"B8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1099\/mic.0.000601","article-title":"Microbe Profile: Mycobacterium tuberculosis: Humanity's Deadly Microbial Foe","volume":"164","author":"Gordon","year":"2018","journal-title":"Microbiology (Reading)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.tiv.2015.02.011","article-title":"The Utility of HepG2 Cells to Identify Direct Mitochondrial Dysfunction in the Absence of Cell Death","volume":"29","author":"Kamalian","year":"2015","journal-title":"Toxicol. Vitro"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/j.bmcl.2008.03.033","article-title":"N-D-aldopentofuranosyl-N'-[p-(isoamyloxy)phenyl]-thiourea Derivatives: Potential Anti-TB Therapeutic Agents","volume":"18","author":"Liav","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1099\/mic.0.000760","article-title":"The Relevance of Persisters in Tuberculosis Drug Discovery","volume":"165","author":"Mandal","year":"2019","journal-title":"Microbiology (Reading)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1016\/j.bmc.2014.12.031","article-title":"Perspective: Challenges and Opportunities in TB Drug Discovery from Phenotypic Screening","volume":"23","author":"Manjunatha","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymeth.2017.03.022","article-title":"A High Content Microscopy Assay to Determine Drug Activity against Intracellular Mycobacterium tuberculosis","volume":"127","author":"Manning","year":"2017","journal-title":"Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"eaaw6635","DOI":"10.1126\/scitranslmed.aaw6635","article-title":"Targeting Redox Heterogeneity to Counteract Drug Tolerance in Replicating Mycobacterium tuberculosis","volume":"11","author":"Mishra","year":"2019","journal-title":"Sci. Transl Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.chembiol.2015.05.016","article-title":"Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG","volume":"22","author":"Mori","year":"2015","journal-title":"Chem. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1099\/mic.0.000797","article-title":"Heterogeneity of ROS Levels in Antibiotic-Exposed Mycobacterial Subpopulations Confers Differential Susceptibility","volume":"165","author":"Nair","year":"2019","journal-title":"Microbiology (Reading)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0199966","DOI":"10.1371\/journal.pone.0199966","article-title":"High Content, High-Throughput Screening for Small Molecule Inducers of NF-\u039ab Translocation","volume":"13","author":"Njikan","year":"2018","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e60531","DOI":"10.1371\/journal.pone.0060531","article-title":"A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis","volume":"8","author":"Ollinger","year":"2013","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/17460441.2020.1707801","article-title":"In Vitro drug Discovery Models for Mycobacterium tuberculosis Relevant for Host Infection","volume":"15","author":"Parish","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"B20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/17460441.2019.1550481","article-title":"Steps to Address Anti-microbial Drug Resistance in Today's Drug Discovery","volume":"14","author":"Parish","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"B21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for Bad Bugs: Confronting the Challenges of Antibacterial Discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.inoche.2015.11.020","article-title":"Anti-Mycobacterium tuberculosis Activity of Platinum(II)\/N,N-disubstituted-N\u2032-acyl Thiourea Complexes","volume":"63","author":"Plut\u00edn","year":"2016","journal-title":"Inorg. Chem. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1021\/acsmedchemlett.9b00204","article-title":"Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis","volume":"10","author":"Poce","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"B24","doi-asserted-by":"publisher","first-page":"12712","DOI":"10.1073\/pnas.231275498","article-title":"Comprehensive Identification of Conditionally Essential Genes in Mycobacteria","volume":"98","author":"Sassetti","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes Required for Mycobacterial Growth Defined by High Density Mutagenesis","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol. Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"12989","DOI":"10.1073\/pnas.2134250100","article-title":"Genetic Requirements for Mycobacterial Survival during Infection","volume":"100","author":"Sassetti","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1003946","DOI":"10.1371\/journal.ppat.1003946","article-title":"Identification of Host-Targeted Small Molecules that Restrict Intracellular Mycobacterium tuberculosis Growth","volume":"10","author":"Stanley","year":"2014","journal-title":"Plos Pathog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1128\/JB.00305-09","article-title":"Acid Resistance in Mycobacterium tuberculosis","volume":"191","author":"Vandal","year":"2009","journal-title":"J. Bacteriol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e1004679","DOI":"10.1371\/journal.ppat.1004679","article-title":"Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium's Metabolism Is Constrained by the Intracellular Environment","volume":"11","author":"VanderVen","year":"2015","journal-title":"Plos Pathog."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.3389\/fmicb.2017.02296","article-title":"Influence of Stress and Antibiotic Resistance on Cell-Length Distribution in Mycobacterium tuberculosis Clinical Isolates","volume":"8","author":"Vijay","year":"2017","journal-title":"Front. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/imr.12266","article-title":"Macrophage Defense Mechanisms against Intracellular Bacteria","volume":"264","author":"Weiss","year":"2015","journal-title":"Immunol. Rev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.790583\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T03:24:01Z","timestamp":1641180241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.790583\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":31,"alternative-id":["10.3389\/fphar.2021.790583"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.790583","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.28.462274","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,3]]},"article-number":"790583"}}